Studies Addressing Rare Neurodegenerative Diseases including ALS: 16% First-Time Win Rate

Studies Addressing Rare Neurodegenerative Diseases including ALS

Food and Drug Administration · HHS

Your odds: program 93.103

A realistic target for an established nonprofit. 16% of awards go to first-time applicants and nonprofits win 20%.

Based on 388 new awards in FY2023–25. The median award is $549,857. Expect about 70 days between posting and deadline.

First-time winners: 16%; of new 93.103 awards
Nonprofit share: 20%; of awards
Median award: $550K; FY2025
New awards, FY2025: 128; 388 in 3 years
Typical window: 70 d; usually posts Jan
Under-$1M orgs: n/a; of nonprofit awards

About this grant

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.

Who can apply

Public & Indian housing authoritiesFederally recognized tribal governmentsIndependent school districtsState governmentsNative American tribal organizationsPublic & state-controlled collegesSmall businessesSpecial district governmentsPrivate colleges & universitiesUnrestricted (open to anyone)County governmentsNonprofits without 501(c)(3) statusFor-profit organizationsCity or township governments501(c)(3) nonprofits

How to apply

Read the full announcement on Grants.gov before you start. Federal applications are submitted through Grants.gov (or the agency's own system) and require a Unique Entity ID from SAM.gov. Registration can take several weeks, so start early. Contact: Terrin Brown Grantor · terrin.brown@fda.hhs.gov · 2404027610

What are the odds for a first-time applicant?

A realistic target for an established nonprofit. 16% of awards go to first-time applicants and nonprofits win 20%. Based on 388 new awards in FY2023–25. The median award is $549,857. Expect about 70 days between posting and deadline.

Who can apply for Studies Addressing Rare Neurodegenerative Diseases including ALS?

Eligible applicants: Public & Indian housing authorities; Federally recognized tribal governments; Independent school districts; State governments; Native American tribal organizations; Public & state-controlled colleges; Small businesses; Special district governments; Private colleges & universities; Unrestricted (open to anyone); County governments; Nonprofits without 501(c)(3) status; For-profit organizations; City or township governments; 501(c)(3) nonprofits.

When is the deadline?

The funder has forecast this opportunity but hasn't announced a deadline yet. Sign up for a reminder and we'll email you when it opens.

Similar open grants

All research grants

Deadline	Grant	Funder	Award ceiling
Rollingno deadline	Google.org — GrantsCorporateGoogle.org	Google.org	Not listed
Rollingno deadline	Alfred P. Sloan Foundation — GrantsFoundationAlfred P. Sloan Foundation	Alfred P. Sloan Foundation	Not listed
Rollingno deadline	Gordon and Betty Moore Foundation — GrantsFoundationGordon and Betty Moore Foundation	Gordon and Betty Moore Foundation	Not listed
Rollingno deadline	Russell Sage Foundation — Research GrantsFoundationRussell Sage Foundation	Russell Sage Foundation	Not listed
Rollingno deadline	Simons Foundation — GrantsFoundationSimons Foundation	Simons Foundation	Not listed
Rollingno deadline	Spencer Foundation — Education Research GrantsFoundationSpencer Foundation	Spencer Foundation	Not listed